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Several genetic  systems have been reported that  regulate  the  antibody re- 
sponse to H-2D  ~ alloantigens  in mice  (1-5).  Some of the  genes described are 
linked to H-2 (2, 3), whereas other genes are located in the extra-H-2 genome (1, 
4, 5). 
In concentrating on the genetic regulation by genes not linked to H-2 we have tried to 
determine the site of gene action in the sequence of immunological  phenomena that leads 
to antibody production. Most experiments have been performed with B10.A(5R) {5R] mice 
immunized with  spleen  cells  from  congenic or  noncongenic H-2  b  mice  (6).  Repeated 
immunizations  with congenic C57BL/10 (B10) cells induces the production of antibodies of 
IgM type only, whereas immunization  with noncongenic  cells induces both IgM and IgG 
antibodies to H-2D  b.  The hypothesis was proposed  (4)  that,  to  mice with the genetic 
background of the B10 series, an H-2 antigen on a congenic cell is analogous to a hapten 
on a nonimmunogenic  carrier (7, 8) which fails to induce the helper T-cell function and 
thereby fails to stimulate the switch from IgM to IgG in B cells. 
In order to support this hypothesis by experimental data we have rendered 5R 
mice tolerant to gene products of the extra-H-2  genome of the  BALB/c mouse 
strain and have compared the noncongenic immunization with BALB.B cells in 
these  tolerized mice  to  the  congenic immunization  with  B10  cells.  The  data 
obtained confirm our hypothesis that non-H-2 cell surface antigens act as carrier 
determinants in an anti-H-2 immunization. 
Materials  and  Methods 
Mice and Immunizations.  All animals used in the experiments reported here were from our 
own colonies of inbred mouse strains. All immunizations were directed against H-2D  b alloanti- 
gens. 5R mice (2- to 6-mo old) were immunized  with normal spleen cells from either B10, A.BY, or 
BALB.B mice or with EL4 leukemia cells, carried by serial passage in B6 or B10 mice. The H-2 
haplotypes of all strains used are shown in Table I. 5R belongs to the series of congenic-resistant 
strains of B10 origin; its H-2  haplotype (H-2  ~'~) is derived from a  crossover  of H-2  ~ and H-2  b 
occurring betweenl-B and I-C (9). B10, EL4, A.BY, and BALB.B all carry the H-2  b haplotype; B10 
and EL4 on the same genetic background as 5R, and A.BY and BALB.B on the background of the 
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unrelated strains A  and  BALB/c,  respectively.  Immunizations of 5R  mice with H-2  ° cells are 
directed against gene products coded for by the I-C  b, S °, and D b region of the H-2 complex. In the 
case of B10 cells, no other foreign cell surface antigens should be recognized; in the case of EL4 
cells, tumor-specific antigens should be recognized in addition to H-2D°;  and in the case of A.BY 
and BALB.B cells, several different non-H-2 antigens are present on the immunizing cell. 
To tolerize 5R mice to cell surface antigens of the BALB/c background, 5R mice were injected 
intravenously during the first 24 h  after birth with 8 x  106 bone marrow cells from adult BALB.K 
(/-/-2  k)  mice  (Table I).  According to  Law  et  al.  this treatment  leads  to  humoral  and  cellular 
tolerance to any cell from the injected strain (10).  As controls, bone marrow cells from B10.BR 
mice were injected, which also carry H-2  k but on the B10 background (Table I). Another set of 
control mice was injected with saline. 
For immunizations, groups of 7-10 mice received a  first inoculation of 0.5  ×  106 cells injected 
subcutaneously; 2 wk later 5 ×  l0  s cells were injected intraperitoneally, and the immunization was 
continued with fortnightly intraperitoneal injections of 10 ×  106 cells. The immunized mice were 
bled  from  the  retroorbital  plexus  7  days  after the fourth,  fifth,  and sixth  immunization.  All 
antisera  were  stored  at  -70°C  until tested.  As  target  cells  in  the  antibody complement  (C)- 
mediated  cytotoxicity  test  B10.HTG  lymph  node  cells  were  chosen  (Table  I);  this  way  only 
antibodies against H-2D  b were assayed. 
C-Mediated  Cytotoxicity  Test.  The  C-mediated  cytotoxicity  test  for  antibody  activity  was 
performed on ~lCr-labeled lymph node cells as previously described (4) with the following modifica- 
tion to allow for greater sensitivity and for the use of 2-mercaptoethanol (2-Me) to test for 2-Me- 
sensitive and 2-Me-resistant antibodies: Instead of a  one-step cytotoxicity assay with an incuba- 
tion time of 1 h  at room temperature,  a  two-step test was used in which the labeled target cells 
were incubated with antiserum in the cold, centrifuged, and then incubated at 37°C with guinea 
pig C.  Disulfide bond reduction of the H-2 antibodies with 2-Me was carried out by incubating 
equal  volumes of serum  and  0.1  M  2-Me for 30 min  at 37°C  as described  by  Klein  et al.  (11) 
assuming that 2-Me-sensitive antibodies are oflgM type, whereas 2-Me-resistant antibodies are of 
IgG type. 
Lymphocyte-Mediated Cytolysis.  The lymphocyte-mediated cytolysis assays were performed as 
previously described (4). As target cells EIA leukemia cells (H-2°), or P815 mastocytoma cells (H- 
2 d, control) were used. Tests were performed 4 clays after the fourth, fifth, and sixth immunization 
with an incubation time of 5 h. 
Results 
Antibody Response of 5R Mice to Congenic and Noncongenic H-2  b Cells.  5R 
mice were immunized with congenic B10 normal spleen cells, with EIA leuke- 
mia cells, or with noncongenic A.BY and BALB.B normal spleen cells. Part of 
TABLE I 
H-2 Haplotype of Atl Mouse Strains Used 
H-2  complex  Non-H-2 
Haplotype  background 
K  I-A  I-B  I-C  S  D 
Responding strain 
5R  H-2 ~ 
Cells used for immunization 
B10  H.2 ~ 
EL4  H-2 b 
A.BY  H-2 ~ 
BALB.B  H-2 ~ 
Bone marrow cells injected into new- 
born  5R mice 
B10.BR  H-2 ~ 
BALB. K  H-2 ~ 
Target cells in antibody C-mediated 
cytocytotoxicity tests 
B 10. HTG  H-2~ 
b  b  b  1"  d  d  d  B10 
b  b  b  b  b  b  B10 
b  b  b  b  b  b  C57BL 
b  b  b  b  b  b  A 
b  b  b  b  b  b  BALB/c 
k  k  k  k  k  k  B10 
k  k  k  k  k  k  BALB/c 
d  d  d  d  d  b  B10 
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Fro.  1.  Antibody levels as  measured by  a  C-mediated 5~Cr-release cytotoxicity assay. 
Titration on B10.HTG target cells of sera collected 7 days after the sixth injection of 5R mice 
with EL4 leukemia cells, or normal spleen cells of strains BALB.B, A.BY, or B10.  Solid 
lines, sera not treated with 2-Me. Broken lines, sera after 2-Me treatment. 
these  results  have  been  described  earlier  (6).  When  tested  in  a  C-mediated 
cytotoxicity test on B10.HTG cells in which only antibodies against cell surface 
antigens  governed by the H-2D  b region  should be detected,  the anti-B10 sera 
showed either a weak IgM response (Fig.  1) or no detectable antibody response 
at all.  In contrast,  all immunizations  with H-2 ~ cells bearing additional  anti- 
genic differences, tumor antigens  on EL4 and non-H-2 antigens on A.BY and 
BALB.B, induced a  stronger response, consisting mostly of 2-Me-resistant anti- 
bodies of IgG type (Fig.  1). Since the IgG antibody response to H-2 antigens is 
thymus  dependent  (11),  we  concluded  that  foreign  cell  surface  antigens  in 
addition to H-2D  b are needed in 5R mice to induce the T-cell helper function 
which is responsible for the switch from IgM to IgG production. 
Induction  of Tolerance  to  the  BALB/c  Background  Gene  Products  in  5R 
Mice.  To test this theory we devised the following experiment:  5R mice were 
made tolerant  to the extra-H-2  genome of BALB/c by injecting  bone marrow 
cells into newborn mice. Instead of using BALB/c mice, bone marrow cells from 
the BALB.K strain (H-2 k on the BALB/c background) were chosen which differ 
from 5R mice at the wholeH-2 complex and not at only part of it as BALB/c. Two 
controls  were  performed:  5R  newborns  were  injected  with  either  saline  or 
congenic B10.BR bone marrow cells (H-2k). These groups of mice are referred to 
as 5R(SALINE), 5R(BALB.K), and 5R(B10.BR). 5R(SALINE) mice should rep- 
resent  normal  controls,  5R(BALB.K)  and  5R(B10.BR)  should  be  tolerant  to 
antigens of the H-2 k haplotype, and 5R(BALB.K) in addition should be tolerant 
to  all  relevant  non-H-2  cell  surface  antigens  of the  extra-H-2  portion  of the 
BALB/c genome. 
At 2 months of age the mice were immunized  with BALB.B normal  spleen 
cells. Fig. 2 gives the results of sera collected 7 days after the sixth injection. As 
expected 5R(SALINE) showed a cytotexicity curve identical to 5R mice that had 
not been handled  as newborns.  In contrast,  in the 5R(BALB.K) anti-BALB.B 
immunization no cytotoxic antibodies to H-2D  b were detected (Fig. 2). In some WERNET  AND  LILLY  BRIEF  DEFINITIVE  REPORT  269 
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Fla. 2.  Antibody levels as measured by a C-mediated s~Or-release cytotoxicity  assay. 
Titration  on B10.HTG target  cells  of  sera collected  7  days after  the sixth  injection  of  5R  mice 
with BALB.B normal spleen cells.  5R mice had been injected  as  newborns with  either  saline 
or B10.BR bone marrow cells  or BALB.K  bone marrow cells.  Solid lines,  sera not treated 
with 2-Me. Broken lines,  sera after  2-Me treatment. 
bleedings a low IgM response of 15% cytotoxicity was seen. This evidence closely 
resembles the results obtained in the congenic 5R anti-B10 immunization.  The 
5R(B10.BR) control exhibited a cytotoxicity curve similar to 5R(SALINE), and 
this  indicates  that  the  induction  of tolerance to the H-2 k  haplotype does not 
interfere with the antibody response to H-2D  ~. The implications of this experi- 
ment are that tolerance to non-H-2 cell surface antigens abolishes the antibody 
response to H-2D  b in 5R mice. 
Cell-Mediated  Immunity  to  H-2D  b  of  5R  Mice,  Rendered  Tolerant  to 
BALB~.  The  cell-mediated  immunity  was  investigated  in  a  5'Cr-release 
killer assay. We have previously shown that killing against H-2D  b under the 
conditions used is T-cell mediated (4). 5R mice, injected as above as newborns, 
were immunized with BALB.B cells. 4 days after the sixth injection peritoneal 
exudate cells were tested as effector cells on ~'Cr-labeled EL4 cells (H-2 b)  and 
control P815 cells  (H-2~).  As can be seen in  Table II peritoneal  exudate cells 
from  5R(SALINE)  and  5R(B10.BR)  killed  over 80%  of EL4  cells  in  5  hours, 
whereas 5R(BALB.K) showed a considerably lower cytotoxicity of at most 30%. 
The cells of all three groups of mice failed to kill P815, indicating specificity of 
the reaction for H-2D  b.  These experiments suggest that tolerance induction to 
the  BALB/c  background  influences,  but  does  not  abolish  the  cell-mediated 
immunity to H-2D  b in an immunization  with BALB.B cells. 
Discussion 
5R mice appear to be capable of mounting an IgG response to immunization 
with cells bearing H-2D  b alloantigens  only if the cells also bear other foreign 
antigens  (e.g.,  non-H-2  or tumor-specific antigens).  Thus  immunization  with 
congenic B10 cells  (H-2b), which differ from 5R essentially only at the H-2D  b 
subregion, elicits only an IgM response,  whereas immunization  with BALB.B 
cells  (H-2 b)  elicits both IgM and  IgG antibodies.  These  results  appear analo- 270  WERNET  AND  LILLY  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
Lymphocyte-Mediated Cytolysis by Perintoneal Exudate Cells from 5R 
Mice Immunized with BALB.B Spleen Cells 
Target cells 
5~Cr release 
5R(SALINE)  5R(BALB.K)  5R(B10.BR) 
%  %  % 
EL4  89  30  81 
P815  4  3  1 
5R mice had been injected as newborns with either saline or BALB.K bone marrow cells or B10.BR bone 
marrow cells.  Peritoneal exudate cells were harvested 4 days after the sixth immunization. Killer to 
target cell ratio 80:1. 
gous to those from immunizations of mice with haptens coupled to syngeneic 
erythrocytes  as nonimmunogenic  carriers (7, 8). Therefore, to 5R mice theH-2D b 
alloantigen on B10 cells would represent a hapten which does not activate helper 
T cells and therefore cannot induce the switch from IgM to IgG production. 
This hypothesis was confirmed by the data presented here. 5R mice were 
made tolerant to cell surface antigens of the BALB/c background by injecting 
BALB.K bone marrow cells (H-2 k)  into newborn 5R mice. In the subsequent 
noncongenic immunization with BALB.B cells, the mice responded as if the 
immunization had been with congenic B10 cells. No IgG antibodies to H-2D  ~ 
could be detected. The cell-mediated immunity to H-2D  ~ was impaired when 
compared to two control groups, but was still detectable. 
Induction of tolerance by injecting allogeneic cells into newborn mice may 
lead to clonal deletion or clonal inactivation of lymphocytes committed to the 
allogeneic cells (12, 13) or may lead to long-lasting suppression of the antigen- 
specific cells by serum-blocking factors (14) or suppressor cells.  In any case no 
cells recognizing gene products of the extra-H-2 BALB/c background could be 
activated in 5R mice injected as newborns with BALB.K cells and thus the 
BALB.B cells behaved as nonimmunogenic  carriers. Under these circumstances 
the H-2D  ~ antigen represents a  single haptenic site which does not lead to 
activation of helper T cells but which is sufficient to stimulate IgM-producing B 
cells and killer T cells. 
These experiments confirm our hypothesis that in a 5R anti-B10 immuniza- 
tion the H-2 antigen is analogous to a hapten on a nonimmunogenic carrier. 
Comparative immunizations have shown that this phenomenon is not unique to 
5R but is demonstrated by other mice of the B10 series (5) and may be shared by 
mice carrying the  genome of strain  A  (3). BALB/c  mice do  not  show this 
phenomenon in a congenic immunization (5). Analysis of the genetic regulation 
of the failure in T-cell helper activation is currently underway. 
Summary 
B10.A(5R) mice (H-2i5), immunized with spleen cells from congenic B10 mice 
(H-2b), responded to alloantigens of the H-2D  b region by producing antibodies of 
only IgM type. In contrast, they produced both IgM and IgG antibodies when 
immunized with noncongenic H-2 b cells that carry other foreign cell surface 
antigens (non-H-2) in addition to H-2D b. A hypothesis was proposed comparing WERNET  AND  LILLY  BRIEF  DEFINITIVE  REPORT  271 
the H-2D # antigen on a congenic cell to a hapten on a nonimmunogenic carrier 
which fails to induce T-cell helper function responsible for the switch from IgM 
to IgG secretion in B cells. Data presented here confirmed this hypothesis. 5R 
mice rendered tolerant to the relevant non,H-2 antigens were unable to mount 
the anti-H-2D b IgG response in a noncongenic immunization. Tolerance induc- 
tion did not lead to abrogation of the T-cell-mediated cytotoxicity. 
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